Pharmaceutical

Opinion: STAT+: How I’m helping companies think through...

Employers and employees could fall into opposing camps, with workers demanding t...

Opinion: What happens when patients beat their doctors ...

Have you ever received test results in your email and found yourself panic-Googl...

Confo Therapeutics and AbCellera partner on GPCR-target...

Confo Therapeutics’s technology stabilises the selected GPCRs in their disease-r...

Streamlining healthcare with AI for drug development

Healthcare R&D teams are increasingly using AI for drug development. Learn more ...

How using AI in clinical trials accelerates drug develo...

The use of AI in clinical trials is improving pharmaceutical R&D, speeding up ti...

The potential of AI in pharma R&D

Developing a new drug is a monumental achievement — the reward of years of resea...

FDA accepts Ipsen’s sNDA for mPDAC therapy

The sNDA was submitted based on data obtained from the Phase III NAPOLI 3 trial.

FDA approves Amneal’s 505(b)(2) NDA for PEMRYDI RTU

PEMRYDI RTU is the first and only ready-to-use presentation of pemetrexed for in...

Sandoz targets barriers to biosimilar accessibility wit...

The company hopes to work with stakeholders to improve access to biosimilars acr...

Eloxx repackages ELX-02 data in cystic fibrosis as it e...

Eloxx reanalysed data from a Phase II trial that previously missed its efficacy ...

Astellas and Cullgen to develop small molecule protein ...

Cullgen received a $35m upfront payment and is eligible for several milestone-ba...

Verve Therapeutics and Lilly partner to advance gene ed...

Lilly will work on the development, manufacture and commercialisation activities...

STAT+: Federal advisory group rejects proposal to make ...

“It’s a setback in patient safety and surveillance,” one expert said, "and will ...

Bacterial infection may be ‘key event’ in common but my...

Endometriosis is in dire need of treatments, and a new study implicating a type ...

STAT+: Health insurance stocks tumble after UnitedHealt...

A top UnitedHealth executive said there's been “a meaningfully higher number” of...

STAT+: Pharmalittle: A not-so-new Biogen?; ALS Associat...

This was supposed to be the new Biogen. Instead, the company's board saddled CEO...